NASDAQ · Medical - Diagnostics & Research

NEO (NEO) Stock

$13.14 -5.40% NASDAQ: NEO Healthcare

Valuation

MetricValue
Price$13.14
Market Cap$342.20M
P/E Ratio-1.96
P/B Ratio0.26
P/S Ratio0.29
EPS (TTM)$-4.20
52-Week High$15.49
52-Week Low$4.72
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-12.90%
ROA-7.94%
ROCE-7.89%
Gross Margin-9.08%
Operating Margin-9.08%
Net Margin-13.30%
Debt/Equity0.49
Current Ratio4.27

Annual Financials (USD)

Metric20212022202320242025
Revenue$484.0M$510.0M$592.0M$661.0M$727.0M
Operating Profit$-119.0M$-158.0M$-108.0M$-92.0M$-66.0M
Net Profit$-8.0M$-144.0M$-88.0M$-79.0M$-108.0M
EPS$-0.35$-5.80$-3.50$-3.10$-4.20
Op Margin-24.5%-30.9%-18.2%-13.9%-9.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.9B$1.7B$1.7B$1.6B$1.4B
Total Liabilities$762.0M$742.0M$740.0M$736.0M$523.0M
Cash$317.0M$263.0M$342.0M$367.0M$160.0M
Borrowings$613.0M$611.0M$612.0M$605.0M$472.0M

Latest News

NEO: What does Argus have to say about NEO? Argus Research · Jul 22, 2026 NeoGenomics Settles DOJ Investigation Related to Laboratory Collaboration Program MT Newswires · Jul 20, 2026 NeoGenomics Announces Settlement of Voluntary Disclosure to OIG-HHS Business Wire · Jul 20, 2026 NeoGenomics (NEO) Stock Looks Above Fair Value After A 134% Run Simply Wall St. · Jul 18, 2026 Is NeoGenomics (NEO) Undervalued After Its FDA Approved PTEN Test Launch? Simply Wall St. · Jul 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-27.0M$-66.0M$-2.0M$7.0M$5.0M
Investing Cash Flow$-697.0M$-30.0M$48.0M$-28.0M$-39.0M
Financing Cash Flow$-32.0M$0$0$0$0
Net Cash Flow$66.0M$-54.0M$79.0M$25.0M$-207.0M
Free Cash Flow$-91.0M$-97.0M$-31.0M$-34.0M$-22.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA263.29
FCF Yield-2.33%
Quick Ratio4.06
Interest Coverage-16.50
Return 1Y115.43%
Return 3Y-14.78%
Return 5Y-66.41%

Ownership

Insiders Held2.05%
Institutions Held108.49%
Institutions Float Held110.76%
Institutional HolderSharesReport Date
Blackrock Inc.19,957,5022026-03-31
First Light Asset Management, LLC9,729,9782026-03-31
Greenhouse Funds, LLLP9,100,1032026-03-31
Vanguard Portfolio Management LLC7,622,1872026-03-31
First Trust Advisors LP6,162,3712026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About NEO

NEO is led by CEO Anthony Zook, employs 2,200 people, headquartered in US, publicly traded since 2004.

NEO stock trades at $13.14 with a market capitalization of $342.20M. The stock is valued at a price-to-earnings (P/E) ratio of -1.96, price-to-book of 0.26, price-to-sales of 0.29. Over the past 52 weeks the stock has ranged between $4.72 and $15.49, and currently trades 15.2% below its 52-week high.

On profitability, NEO generates a return on equity (ROE) of -12.90%, return on capital employed of -7.89%, an operating margin of -9.08%, a net profit margin of -13.30%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides